Objectives: CYP2D6 polymorphism of clinical relevance occurs with variable
frequency in different ethnic groups. Since this polymorphism has not been
studied in a North Indian population, the present study was undertaken.
Methods: One hundred healthy unrelated North Indian subjects received 30 mg
dextromethorphan (DM) orally at bed-time. The amounts of DM and its metabo
lite, dextrorphan (DR), excreted in 8 h urine were estimated by high perfor
mance liquid chromatography. Metabolic ratio (DM/DR excreted in 8 h) was us
ed as an index of the metabolic status of an individual.
Results: The analysis of the data by frequency distribution histogram, prob
it and NTV plots demonstrated bimodal distribution of the North Indian subj
ects with respect to hepatic CYP2D6. Out of 100 subjects, 97 were extensive
metabolizers (EMs), whereas three were poor metabolizers (PMs). EMs and PM
s excreted 29.82 and 2.67 mu mol DR (mean value) and 2.59 and 8.82 mu mol D
M (mean value) in 8 h, respectively. MR and log MR was 197- and 2.2-fold hi
gher in PMs versus EMs. The antimode value of zero was determined by visual
observation in frequency distribution histogram and inflection point in pr
obit plot.
Conclusion: From this study, it can be concluded that the PM phenotype of C
YP2D6 occurs with a frequency of 3% (95% confidence interval of 0.33%-6.33%
) in North Indians.